Stem Cells from Urine - A Breakthrough in the Treatment of Kidney Failure

EHL BIO medical staff care for patients treated for renal failure and chronic kidney disease using urine stem cell therapy

Chronic kidney disease and kidney failure have become a serious health problem, affecting millions of people and families worldwide.

EHL BIO Cell Institute - Korea's leading research and development (R&D) institute in the field of stem cells and public health - has developed a new treatment technology using stem cells from urine.

According to a reporter in Korea, the above technology is a breakthrough therapy developed for the first time in the world, bringing new hope to patients with kidney failure and chronic kidney disease.

One of the notable new achievements of the EHL BIO Cell Institute is the research and development of cell therapy extracted from urine excreted by the kidneys to focus on treating kidney-related diseases.

Sharing with reporters in Korea, Dr. Lee Hong-ki, Director of the EHL BIO Cell Institute, said that according to a survey, over the age of 50, 1 in 5 people have kidney problems, the most typical of which is kidney failure.

Dr. Lee Hong-ki, Director of EHL BIO Cell Institute (Korea) shares information about the technology of treating kidney failure and chronic kidney disease using stem cell therapy from urine.

For this disease, the usual progression is that the patient eventually has to undergo dialysis, also known as blood filtration.

The underlying cause of this disease is mostly due to age, complications of diabetes, high blood pressure and currently there is almost no way to restore kidney function.

However, stem cells extracted from urine excreted by the kidneys are considered a breakthrough method to regenerate kidney function and thereby improve the condition.

Klotho protein is a special protein found in the human body, especially in kidney, brain and bone tissues.

This protein is named after the Greek goddess Klotho, who had the ability to regulate longevity and bring youthfulness to humans.

Klotho protein plays an important role in regulating the aging process and maintaining human body functions.

Klotho has the ability to affect many systems in the body, including calcium and phosphate metabolism, water and salt balance, and both the survival and death of cells.

In kidney tissue, Klotho protein helps regulate salt and water balance, while protecting and maintaining kidney function, having anti-inflammatory, antioxidant properties, and preventing kidney function decline.

Deficiency or reduced synthesis of Klotho protein can cause health problems, including kidney failure and diseases of aging.

According to Dr. Lee Hong-ki, the application of Klotho culture technology in the treatment of chronic kidney disease and renal failure offers hope for restoring kidney function and improving the quality of life of patients.

When Klotho is enhanced in urine stem cell culture, it can support the regeneration and restoration of damaged kidney cells, while reducing inflammation and enhancing antioxidant function.

Klotho culture technology is considered one of the potential methods in the medical field and continues to be researched and developed to bring health benefits to humans.

Culturing Klotho into stem cells from urine before infusing it into the patient's body has produced impressive results in regenerating and restoring impaired kidney function.

The difference is that unlike stem cells taken from fat tissue or immune cells taken from blood - with easy preservation process, stem cells from urine are very susceptible to damage due to contamination, so many units are researching and developing have to give up halfway.

EHL BIO alone has achieved great success by receiving a patent on the method of cultivating stem cells from urine.

“More specifically, we are also the first unit in the world to be licensed to conduct clinical trials of this therapy when we proved its effectiveness for kidney failure and chronic kidney disease,” Mr. Lee Hong-ki emphasized.

The EHLBIO Cell Institute's approach using stem cells from urine to treat chronic kidney disease and renal failure has been shown to be safe and effective in the first clinical study on a number of patients.

According to VNA